ROGERS MICHAEL W 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 27, 2019
Insider Transaction Report
Form 4
ROGERS MICHAEL W
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-25+40,000→ 40,000 totalExercise: $2.65From: 2019-06-25Exp: 2020-06-25→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Reflects the closing price of the Company's common stock on February 21, 2019, which was the date the option grant was approved by the Compensation Committee of the Board of Directors (the "Committee") of EyePoint Pharmaceuticals, Inc. (the "Registrant"), subject to stockholder approval of an amendment to the Registrant's 2016 Long Term Incentive Plan (the "Plan Amendment").
- [F2]The option grant was approved by the Committee on February 21, 2019, subject to stockholder approval of the Plan Amendment. The Registrant's stockholders approved the Plan Amendment on June 25, 2019.
- [F3]The option to purchase, which vested immediately upon Mr. Rogers' departure from the Board, will be exercisable until June 25, 2020